Copyright
©The Author(s) 2019.
World J Gastroenterol. Jun 7, 2019; 25(21): 2636-2649
Published online Jun 7, 2019. doi: 10.3748/wjg.v25.i21.2636
Published online Jun 7, 2019. doi: 10.3748/wjg.v25.i21.2636
Figure 4 Images in a 65-year-old woman with a solitary hepatocellular carcinoma (tumor size 2.
1 cm) in segment VII. A and B: Axial view of T2- and T1-weighted magnetic resonance images with fat suppression before administration of gadolinium ethoxybenzyl diethylene-triaminepentaacetic acid; C: Arterial phase showing hyperenhancing mass in segment VII; D: Portal venous phase with notable washout appearance of the hepatocellular carcinoma; E: Hepatobiliary phase, axial view of T1-weighted three-dimensional gradient-echo magnetic resonance image with fat suppression. The hypointense rim (arrow) is noted. Postoperatively, pT1 hepatocellular carcinoma was diagnosed.
- Citation: Chou YC, Lao IH, Hsieh PL, Su YY, Mak CW, Sun DP, Sheu MJ, Kuo HT, Chen TJ, Ho CH, Kuo YT. Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma. World J Gastroenterol 2019; 25(21): 2636-2649
- URL: https://www.wjgnet.com/1007-9327/full/v25/i21/2636.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i21.2636